Wolverine Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Wolverine Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,600	Closed	-$21K	–	1509
2016 Q4	$21K	Sell	1,600 -46,500	-97%	-$795K	﹤0.01%	1083
2016 Q3	$1.14M	Buy	48,100 +12,700	+36%	+$341K	0.02%	532
2016 Q2	$1.02M	Buy	+35,400	New	+$1.15M	0.02%	568
2016 Q1	–	Sell	-64	Closed	-$4K	–	1805
2015 Q4	$4K	Hold	64	–	–	﹤0.01%	1523
2015 Q3	$29K	Buy	+64	New	+$2.88K	﹤0.01%	1402

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wolverine Asset Management's IPXL Position: Q1 2016 in Review

Wolverine Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2016, closing a stake of 2,480 shares — an estimated $106K sold.

Wolverine Asset Management first reported a position in IPXL in Q4 2015 and held it in 1 quarter. The position peaked at $106K in Q4 2015. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

Wolverine Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2016 after selling out during the quarter.
Wolverine Asset Management sold 2,480 Impax Laboratories, Inc. shares in Q1 2016, an estimated $106K.
Wolverine Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 1 quarter.
Wolverine Asset Management's Impax Laboratories, Inc. position peaked at $106K in Q4 2015.
194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on Wolverine Asset Management's 13F filing for Q1 2016, filed 16 May 2016.